| アブストラクト | The Vaccine Adverse Event Reporting System database has been used to report adverse events following several vaccines. We studied the patient population predisposed to such reactions and how these reactions differ with respect to the vaccine type. We searched the electronic databases PubMed, EMBASE, and Scopus up to 9 July 2021 for any study describing cardiac adverse events attributed to the vaccination. A total of 56 studies met the criteria comprising 340 patients. There were 20 studies describing cardiac adverse events following smallpox vaccination, 11 studies describing adverse events after influenza vaccination, and 18 studies describing adverse events after COVID-19 vaccination. There was a total of six studies describing cardiac adverse events after the pneumococcal vaccine, tetanus toxoid, cholera vaccine, and rabies vaccine. Adverse events following influenza vaccination occurred more commonly in older females within an average duration of four days from vaccination. Pericardial involvement was the most reported adverse event. Adverse events following COVID-19 vaccination happened at a mean age of 42.7 years, more commonly in males, and mostly after a second dose. Adverse events following smallpox vaccination occurred more commonly in younger males, with an average onset of symptoms from vaccination around 16.6 days. Adverse events were mostly myopericarditis; however, the acute coronary syndrome has been reported with some vaccines. |
|---|
| ジャーナル名 | Vaccines |
|---|
| Pubmed追加日 | 2022/5/29 |
|---|
| 投稿者 | Parmar, Kanak; Subramanyam, Sai; Del Rio-Pertuz, Gaspar; Sethi, Pooja; Argueta-Sosa, Erwin |
|---|
| 組織名 | Department of Internal Medicine, Texas Tech University Health Sciences Center,;Lubbock, TX 79430, USA.;School of Medicine, Vydehi Institute of Medical Sciences and Research Centre,;Bangalore 560048, India.;Department of Cardiovascular Medicine, Texas Tech University Health Sciences;Center, Lubbock, TX 79430, USA. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/35632455/ |
|---|
